Navigation Links
Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome
Date:1/15/2014

ibitors of MetAP2 reduce the production of new fatty acid molecules by the liver and help to convert stored fats into useful energy.  Beloranib is being developed as a twice-weekly subcutaneous injection for severe obesity.  Zafgen holds exclusive worldwide rights (exclusive of Korea) for development and commercialization of beloranib.  The company licensed beloranib from CKD Pharma in Korea.

About Zafgen, Inc. 
Zafgen is an innovative company dedicated to addressing the unmet need of severely obese patients and related orphan indications by bringing beloranib, a first-in-class novel medicine, to market.  Founded in 2005 as a virtual company, Zafgen brings together leading experts in obesity and metabolic disease to address the underserved and growing population of patients who are severely obese.  Zafgen's singular focus is on advancing novel therapeutics for patients suffering from severe obesity and obesity-related disorders including Prader-Willi syndrome and patients with hypothalamic obesity, including obesity resulting from surgical treatment of craniopharyngioma.  The company is located in Cambridge, MA.  For more information, visit zafgen.com.


'/>"/>
SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
2. Zafgen Secures $21 Million in Series D Financing
3. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
4. Zafgen Secures $45 Million in Series E Financing
5. Zafgen Appoints Chief Commercial Officer and New Member of Board of Directors
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... TUCSON, Ariz. , Aug. 20, 2014 /PRNewswire/ ... of the  Roche  Group, today announced that its ... been CE marked in the European Union for ... specimens. The system, consisting of VENTANA Virtuoso software ... the VENTANA iScan HT slide scanner, provides automated ...
(Date:8/20/2014)... Aug. 20, 2014  Amerigen Pharmaceuticals Ltd. announces that ... has received Chinese FDA (CFDA) approval and has ... into the China domestic ... distribution agreement with Sinochem Jiangsu Pharmaceutical Co., Ltd., ... FDA approved and China CFDA certified oral solid ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that a ... catalogue: The Market for Medical Devices ... The European, Middle Eastern and African markets represent ... part of its coverage, this study: The Market ... EMEA medical device markets and estimates markets for ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5
...   " The   Obama administration will ... urban counterparts in adopting technology to improve healthcare quality." ... online health records . " What ... national healthcare IT programmes and initiatives are currently taking place across ...
... WHITE PLAINS, N.Y., Aug. 19, 2011 Today the ... to treat two types of rare blood cancers – ... (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO) The drug is approved ... cell transplant or two chemotherapy treatments and for ALCL ...
Cached Medicine Technology:Innovations in E-Health & Informatics Europe: The Need for a European EHealth Strategy 2The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977 2
(Date:8/20/2014)... Top10BestSEOHosting.com is a website dedicated to providing ... is headed by a team of experts and ... information and factual studies about the newest hosting ... , Recently, Top10BestSEOHosting.com has compared many Linux ... and Bluehost are the most recommended suppliers for ...
(Date:8/20/2014)... Today, Zane Benefits, the #1 ... a new eBook, Affordable Care Act 101. , ... feel uncertain about how the ACA impacts their ... line. , The new eBook outlines key ACA ... their upcoming health insurance decisions. , Read the ...
(Date:8/20/2014)... -- A group representing U.S. obstetricians is calling for ... According to the American College of Obstetricians and Gynecologists ... the safety and effectiveness of flu vaccination during pregnancy. ... be particularly dangerous to pregnant women, as it can ... Riley, chair of the college,s Immunization Expert Work Group, ...
(Date:8/20/2014)... than 42 percent of women underwent breast reconstruction ... associated with foregoing reconstruction included being black, having ... Author: Monica Morrow, M.D., of the Memorial Sloan ... Background: The Women,s Health and Cancer Rights Act ... following a mastectomy. Still, most women who undergo ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Hundreds of ... behalf of women who were allegedly injured due to ... in New Jersey’s Bergen County Superior Court, Bernstein Liebhard ... on August 15, 2014, the Court has established procedures ... Mirena lawsuits that are part of the proceeding’s initial ...
Breaking Medicine News(10 mins):Health News:New Reviews For Linux Web Hosting Suppliers Announced By Top10BestSEOHosting.com 2Health News:All Pregnant Women Need Flu Shot: Ob/Gyn Group 2Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit News: Case Management Order Issued in New Jersey Mirena Litigation, Bernstein Liebhard LLP Reports 4
... , THURSDAY, Nov. 24 (HealthDay News) -- Black Friday, the ... the quest as it is about getting good deals, according ... the Black Friday adventure phenomenon, the more fun you,re likely ... professor at Wake Forest University, said in a university news ...
... THURSDAY, Nov. 24 (HealthDay News) -- The holiday season can ... there are a number of things they can do to ... because many traditional holiday foods contain such allergens as wheat, ... news release from the American College of Allergy, Asthma and ...
... or processed meat is positively associated with aggressive prostate cancer, ... journal PLoS ONE . The research ... Francisco, also found that the correlation was primarily driven by ... done. They suggest that this result, which was ...
... HealthDay Reporter , WEDNESDAY, Nov. 23 (HealthDay ... not an asthma diagnosis are often prescribed inhaled steroid ... those medications on an as-needed basis instead of every ... wheezing in young children, and the treatment for some ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Nov. ... that the drug company Merck will pay $950 million to ... which was pulled from the market in 2004 after studies ... stroke. Merck will pay $321.6 million in criminal ...
... the numbers indicate that improvements are possible," says Hyland at ... in Boston, USA, 234 million major surgical procedures are conducted ... human beings undergoes a major surgical procedure each year. ... According to the WHO, serious complications occur in three to ...
Cached Medicine News:Health News:Allergy Sufferers Should Prepare for Holiday Triggers 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 2Health News:Intermittent Steroid Use Called OK for Wheezing Preschoolers 3Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 2Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 3Health News:Creating safer surgery to save more lives 2Health News:Creating safer surgery to save more lives 3
... An APTT-based kit for the screening of ... specificity of the test for the factor ... sample plasma with an excess of V-DEF ... possible to discriminate between heterozygous and homozygous ...
Inquire...
Inquire...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
Medicine Products: